Delivery Order SPE2DB22D3501-SPE2DB25FUR89

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,851.20 firm fixed-price delivery order is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,082.90, is for the delivery of epinephrine 0.3 mg auto-injectors. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,238.09, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,279.79, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The contract has an ultimate completion date of June 7, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.64 firm fixed-price delivery order is for the supply of 4560650301 - EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,401.12 firm fixed price delivery order is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical commodity. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The $8,647.10 firm fixed-price delivery order contract has a completion date of May 1, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,372.88 firm fixed-price delivery order contract is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,007.70, is for the delivery of epinephrine 0.3 mg auto-inject medical devices. This is a firm fixed-price delivery order contract with a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,851.38 firm fixed-price delivery order contract is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products. The award has an ultimate completion date of December 30, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUR89
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.24, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. This is a firm fixed-price delivery order contract with a completion date of February 25, 2025. The contract is not designated as a set-aside award.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/1/25, 3:16 AM